Rational design and pre-clinical pharmacology of drugs for reversing multidrug resistance
Open Access
- 9 January 1992
- journal article
- review article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 43 (1) , 103-107
- https://doi.org/10.1016/0006-2952(92)90667-8
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Cell surface actions of adriamycinPharmacology & Therapeutics, 1991
- Level of protein kinase C activity correlates directly with resistance to adriamycin in murine fibrosarcoma cellsFEBS Letters, 1989
- Expression of Multidrug Resistance Gene in Human CancersJNCI Journal of the National Cancer Institute, 1989
- Sequence of mdr3 cDNA encoding a human P-glycoproteinGene, 1988
- Role of the Glutathione Redox Cycle in Acquired and de Novo Multidrug ResistanceScience, 1988
- Phosphorylation of the multidrug resistance associated glycoproteinBiochemistry, 1987
- Inhibition of protein kinase C by antineoplastic agents: Implications for drug resistanceBiochemical and Biophysical Research Communications, 1987
- Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cellsCell, 1986
- Mammalian multidrug resistance gene: Complete cDNA sequence indicates strong homology to bacterial transport proteinsCell, 1986
- Drug interaction with calmodulin: The binding siteJournal of Theoretical Biology, 1983